Directors

Linda Peters, MedImmune Ventures

Linda J. Peters joined MedImmune as senior vice president, regulatory affairs, in February 2005. In this role, she is responsible for defining and orchestrating the company’s global regulatory strategy. Also, Ms. Peters is a member of the board of directors of Sequoia Pharmaceuticals.

Prior to joining MedImmune, Ms. Peters was vice president of global regulatory affairs for Baxter Healthcare’s BioScience and Renal businesses, where she was responsible for implementing global regulatory strategies for biologics, vaccines, drugs, biosurgical products and devices. Also, she served as director of regulatory affairs at Takeda Pharmaceuticals North America and held positions of increasing responsibility at TAP Pharmaceuticals.

She earned her bachelor of science and master of science degrees in animal science from Southern Illinois University, and a master of business administration degree from the J.L. Kellogg School of Management at Northwestern University.